[Unexpected protective role of interferon-alpha against Mycobacterium tuberculosis during the course of hepatitis C antiviral therapy].
Nahon
Pierre
P
Brugiere
Olivier
O
Marcellin
Patrick
P
Valla
Dominique
D
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D009169:Mycobacterium tuberculosis / Q000472:pathogenicity; D014397:Tuberculosis, Pulmonary / Q000473:pathology / Q000517:prevention & control*
D000998:Antiviral Agents; D016898:Interferon-alpha